Features

3M™ Curos Jet™ Disinfecting Cap CFJ1-270

The 3M™ Curos Jet™ Disinfecting Cap is a passive disinfection device engineered to protect needleless IV access sites from contamination between uses. Developed by Curos (now part of Solventum Corporation), the Curos Jet™ delivers a consistent, measured dose of 70% isopropyl alcohol directly to the connector surface no scrubbing required, no technique variability, no guesswork.

The Case for Passive Disinfection

Central line associated bloodstream infections (CLABSIs) remain one of the most preventable and costly complications in acute care. Manual scrub the hub protocols are effective in theory but inconsistent in practice: scrub duration, pressure, and drying time vary by clinician and shift. The Curos caps remove that variability. Once threaded onto a needleless connector, the cap delivers a controlled alcohol dose and maintains a sterile barrier until the next access, making passive disinfection a reliable, protocol friendly alternative to manual scrubbing.

Key Features

• Passive disinfection no scrubbing required; alcohol is delivered automatically upon cap application
• 70% isopropyl alcohol (IPA) disinfectant pre loaded in each cap
• Designed for use with most standard needleless connectors
• Single use, disposable eliminates reuse risk and simplifies compliance documentation
• Color coded cap aids visual identification and workflow integration
• Supports CLABSI prevention bundles and Joint Commission compliance initiatives
• Manufactured by Solventum Corporation (formerly 3M Health Care)

Intended Use

Indicated for disinfection of needleless IV connectors on central venous catheters, peripheral IVs, and other intravascular access devices in hospital, long term,  acute care, and outpatient infusion settings. Replace cap at each line access or per facility protocol.

Product Details

• Manufacturer: Solventum Corporation (3M)
• Catalog No.: CFJ1-270
• Ordering SKU: 1020992

Available Configurations

• Single box for unit level stocking or evaluation
• Full case for formulary purchasing and high volume IV therapy programs